Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia.
Amalia HasnidaMaarten Olivier KokElizabeth PisaniPublished in: BMJ global health (2021)
Market factors, including political pressure to reduce medicine prices and healthcare provider incentives, can drive markets for substandard and falsified medicines. To protect progress towards UHC, policy-makers must consider the potential impact on medicine quality when formulating rules governing health financing, procurement, taxation and industry.